We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The quantification of HER2 and MYC gene fragments in cell-free plasma as putative biomarkers for gastric cancer diagnosis.
- Authors
Park, Kyoung Un; Lee, Hee Eun; Nam, Soo Kyung; Nam, Kyung Han; Park, Do Joong; Kim, Hyung-Ho; Kim, Woo Ho; Lee, Hye Seung
- Abstract
Background: This study aimed to investigate the significance of circulating HER2 and MYC gene fragments quantification in the diagnosis of gastric cancer. Methods: Levels of HER2 and MYC genes were evaluated by fluorescence in situ hybridization and real-time PCR in 81 gastric cancer tissues, and by real-time PCR in 36 gastritis tissues. Real-time PCR for HER2 and MYC products was also performed on 184 plasma samples from 81 gastric cancers, eight gastric adenomas, 63 gastritis patients, and 32 healthy individuals. Results: HER2/HBB and MYC/HBB ratios in tissue and cell-free plasma from gastric cancer patients were significantly higher than those of gastritis tissue and cancer-free individuals. An optimized cut-off value of plasma target gene to HBB ratio, used to differentiate cancer patients from cancer-free individuals, was evaluated using receiver operating characteristic (ROC) curves. Values of 2.0 were calculated for HER2 [area under the ROC curve (AUC), 0.760] and 2.725 for MYC (AUC, 0.767). A combination model of HER2 and MYC provided a better differentiation condition than that for HER2 or MYC only (AUC, 0.850). HER2/HBB ratios in plasma from gastric cancer patients correlated with MYC/HBB ratios. Conclusions: Our findings suggest that the measurement of plasma HER2 and MYC gene levels could improve the screening of gastric cancer.
- Subjects
TUMOR markers; CANCER diagnosis; STOMACH cancer; CLINICAL chemistry; CANCER genetics; GENETICS
- Publication
Clinical Chemistry & Laboratory Medicine, 2014, Vol 52, Issue 7, p1033
- ISSN
1434-6621
- Publication type
Article
- DOI
10.1515/cclm-2013-0988